Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
Search in posts
Search in pages
Filter by Categories
BENCH-PRESS : Original Article
BEYOND CLINICAL ONCOLOGY : Original Article
Brainteaser
BREAST CANCER : Original Article
BREAST CANCERS Original Article
Brief Commentary MEDic LAWgic Section
Brief Report, Public Health
CANCER EPIDEMIOLOGY: Original Article
CANCER SURGERY : Original Article
Cardio-Oncology
Case Report
Case Series, Haematological
CLINICAL TRIAL : Original Article
COLORECTAL CANCER : Original Article
COMMENTARY
Consensus
Consensus Recommendations, Head Neck
Controversy
Corrigendum
Diagnostic Dilemma
Drug Review
DRUG REVIEW : Review Article
Editorial
Editorial Commentary
Editorial: Memoir
Erratum
ESOPHAGEAL CANCER : Original Article
FEMALE REPRODUCTIVE TRACT TUMORS : Original Article
GCT Review Article
GENITOURINARY : Original Article
GI CANCER Original Article
HEAD AND NECK CANCER : Original Article
HEAD AND NECK CANCER : Review Article
HEAD AND NECK CANCERS : Original Article
HISTOPATHOLOGY IN ONCOLOGY : Original Article
In Response
Letter to Editor
Letter to Editor, Breast
Letter to Editor: Oral Carcinoma
Letter to the Editor
Letters to Editor
Letters to the Editor
LEUKEMIA : Original Article
LEUKEMIAS : Original Article
LUNG CANCER: Original Article
METRONOMIC THERAPY IN AML : Original Article
METRONOMIC THERAPY IN HEAD AND NECK CANCERS : Original Article
METRONOMIC THERAPY IN LUNG CANCER : Original Article
METRONOMIC THERAPY IN OVARIAN CANCER : Original Article
Mini Commentary
Mini Symposium - FNAC VERSUS CORE BIOPSY: Editorial
Mini Symposium - FNAC VERSUS CORE BIOPSY: Original Article
Mini Symposium - RT DOSIMETRY AND FRACTIONATION: Editorial
Mini Symposium - RT DOSIMETRY AND FRACTIONATION: Original Article
Mini Symposium on Changing Landscape: Brief Article
Mini Symposium on Changing Landscape: Editorial
Mini Symposium on Changing Landscape: Original Article
Mini Symposium on CML
Mini Symposium on Supportive Care: Original Article
MINI SYMPOSIUM: HEAD AND NECK CANCER : Editorial
MINI SYMPOSIUM: HEAD AND NECK CANCER : Original Article
MINI SYMPOSIUM: HEAD AND NECK CANCER : Review Article
MINI SYMPOSIUM: HEAD AND NECK ONCOLOGY: Original Article
MINI SYMPOSIUM: MOLECULAR ONCOLOGY: Original Article
MINI SYMPOSIUM: PEDIATRIC ONCOLOGY: Original Article
MISCELLANEOUS : Original Article
MOLECULAR ONCOLOGY : Original Article
MULTIPLE CANCERS Original Article
MYELODYSPLASTIC SYNDROME : Review Article
MYELOID LEUKEMIA : Original Article
NEURO ONCOLOGY : Review Article
NEURO-ONCOLOGY : Original Article
None
Notice of Retraction
OESOPHAGEAL CANCER : Original Article
Oncology Reflections
Original Article
Original Article : Bone & Soft Tissue Tumors
ORIGINAL ARTICLE : Bone and Soft Tissue Sarcomas
ORIGINAL ARTICLE : Breast Cancer
Original Article : Breast Cancers
Original Article : Gastro-intestinal & Hepatobiliary Cancers
Original Article : Genitourinary & Gynecological Cancers
ORIGINAL ARTICLE : GI Cancer
ORIGINAL ARTICLE : GI Oncology
ORIGINAL ARTICLE : Gynaecologic Oncology
Original Article : Head and Neck Cancers
ORIGINAL ARTICLE : Hematolymphoid
Original Article : Leukemia & Lymphoma
ORIGINAL ARTICLE : Leukemia and Lymphoma
ORIGINAL ARTICLE : Melanoma and Skin Cancer
Original Article : Pediatric and Adolescent Cancers
ORIGINAL ARTICLE : SAARC Selection
ORIGINAL ARTICLE : Supportive Care and Others
Original Article, Breast
Original Article, Gastrointestinal
Original Article, Gynaecological
Original Article, Head Neck
Original Article, Neurological
Original Article, Public Health
Original Article: Bladder Cancer
Original Article: Bone and Soft Tissue Cancers
Original Article: Bone and Soft Tissue Tumor
ORIGINAL ARTICLE: Bone and Soft Tissue Tumors
Original Article: Brain Tumor
ORIGINAL ARTICLE: Brain Tumors
Original Article: Cancer Epidemiology and Screening
Original Article: Cancer Epidemiology, Screening and diagnosis
ORIGINAL ARTICLE: Diagnostics in Oncology
ORIGINAL ARTICLE: Epidemiology of Cancer and Cancer Screening
ORIGINAL ARTICLE: Gastro-intestinal & Hepatobiliary Cancer
Original Article: Gastrointestinal Cancer
Original Article: Genito Urinary Cancer
ORIGINAL ARTICLE: Genitourinary & Gynaecological Cancer
Original Article: Genitourinary Cancer
ORIGINAL ARTICLE: Genitourinary Cancers
Original Article: Geriatric Oncology
ORIGINAL ARTICLE: GI Cancers
Original Article: GI Cancers and Hepatobilliary Malignancies
ORIGINAL ARTICLE: Gynaecologic Cancers
ORIGINAL ARTICLE: Gynaecological Cancer
ORIGINAL ARTICLE: Gynaecological Cancers
Original Article: Gynecological Cancer
ORIGINAL ARTICLE: Head and Neck Cancer
ORIGINAL ARTICLE: Hematolymphoid Malignancies
Original Article: Hematolymphoid Malignancy
Original Article: Hepatobiliary Cancer
ORIGINAL ARTICLE: Immuno - Oncology
Original Article: Leukemia -Lymphoma and Myeloma
ORIGINAL ARTICLE: Leukemia, Lymphoma & Plasma Cell Disorder
Original Article: Lung Cancer
ORIGINAL ARTICLE: Lung Cancers
ORIGINAL ARTICLE: Neuroendocrine Tumors
Original Article: Paediatric Cancer
ORIGINAL ARTICLE: Palliative Care
ORIGINAL ARTICLE: Pediatric Oncology
ORIGINAL ARTICLE: Sarcomas
ORIGINAL ARTICLE: Sarcomas and Skin Cancer
Original Article: Skin Cancer
Original Article: Supportive and Palliative Care
Original Article: Supportive and Palliative Care in Cancer
ORIGINAL ARTICLE: Supportive Care
Original Research Article
PEDIATRIC ONCOLOGY : Original Article
PEDIATRIC SECTION: Editorial
PEDIATRIC SECTION: Original Article
Pictorial CME, Haematological
Poetry in Oncology
Position Paper
QUEST FOR AN ANTIDOTE TO RADIATION TOXICITY : Editorial
QUEST FOR AN ANTIDOTE TO RADIATION TOXICITY : Original Article
RCC Practical Consensus Recommendations
Regional Article
Review Article
Review Article, Breast
Review Article, Haematological
Review Article, International
SARCOMA : Original Article
SARCOMA Review Article
SOFT TISSUE SARCOMA : Original Article
South Asia update
SOUTH ASIAN UPDATE : An update
SOUTH ASIAN UPDATE : Original Article
TABACCO, THE MENACE : Original Article
THE CUTTING EDGE OF RADIOTHERAPEUTICS : Editorial
THE CUTTING EDGE OF RADIOTHERAPEUTICS : Original Article
THE GREAT DEBATE: Against HPV vaccine in cervical cancer
THE GREAT DEBATE: AGAINST IMATINIB AS THE FIRST LINE TKI CHOICE FOR CML
THE GREAT DEBATE: Editorial-HPV vaccine in cervical cancer
THE GREAT DEBATE: For HPV vaccine in cervical cancer
THE GREAT DEBATE: FOR IMATINIB AS THE FIRST LINE TKI CHOICE FOR CML
THE GREY-HAIRED CANCER PATIENT: Editorial
THE GREY-HAIRED CANCER PATIENT: Original Article
THE SKILLFUL SCALPEL: Editorial
THE SKILLFUL SCALPEL: Original Article
THE WAR ON MICROBES: Editorial
THE WAR ON MICROBES: Original Article
THROUGH THE MICROSCOPE : Original Article
THROUGH THE MICROSCOPE: Editorial
TREATMENT TOXICITY : Original Article
TRENDS IN HORMONAL THERAPY IN PROSTATE CANCER: Review Article
URO-ONCOLOGY : Original Article
View Point
Viewpoint
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
Search in posts
Search in pages
Filter by Categories
BENCH-PRESS : Original Article
BEYOND CLINICAL ONCOLOGY : Original Article
Brainteaser
BREAST CANCER : Original Article
BREAST CANCERS Original Article
Brief Commentary MEDic LAWgic Section
Brief Report, Public Health
CANCER EPIDEMIOLOGY: Original Article
CANCER SURGERY : Original Article
Cardio-Oncology
Case Report
Case Series, Haematological
CLINICAL TRIAL : Original Article
COLORECTAL CANCER : Original Article
COMMENTARY
Consensus
Consensus Recommendations, Head Neck
Controversy
Corrigendum
Diagnostic Dilemma
Drug Review
DRUG REVIEW : Review Article
Editorial
Editorial Commentary
Editorial: Memoir
Erratum
ESOPHAGEAL CANCER : Original Article
FEMALE REPRODUCTIVE TRACT TUMORS : Original Article
GCT Review Article
GENITOURINARY : Original Article
GI CANCER Original Article
HEAD AND NECK CANCER : Original Article
HEAD AND NECK CANCER : Review Article
HEAD AND NECK CANCERS : Original Article
HISTOPATHOLOGY IN ONCOLOGY : Original Article
In Response
Letter to Editor
Letter to Editor, Breast
Letter to Editor: Oral Carcinoma
Letter to the Editor
Letters to Editor
Letters to the Editor
LEUKEMIA : Original Article
LEUKEMIAS : Original Article
LUNG CANCER: Original Article
METRONOMIC THERAPY IN AML : Original Article
METRONOMIC THERAPY IN HEAD AND NECK CANCERS : Original Article
METRONOMIC THERAPY IN LUNG CANCER : Original Article
METRONOMIC THERAPY IN OVARIAN CANCER : Original Article
Mini Commentary
Mini Symposium - FNAC VERSUS CORE BIOPSY: Editorial
Mini Symposium - FNAC VERSUS CORE BIOPSY: Original Article
Mini Symposium - RT DOSIMETRY AND FRACTIONATION: Editorial
Mini Symposium - RT DOSIMETRY AND FRACTIONATION: Original Article
Mini Symposium on Changing Landscape: Brief Article
Mini Symposium on Changing Landscape: Editorial
Mini Symposium on Changing Landscape: Original Article
Mini Symposium on CML
Mini Symposium on Supportive Care: Original Article
MINI SYMPOSIUM: HEAD AND NECK CANCER : Editorial
MINI SYMPOSIUM: HEAD AND NECK CANCER : Original Article
MINI SYMPOSIUM: HEAD AND NECK CANCER : Review Article
MINI SYMPOSIUM: HEAD AND NECK ONCOLOGY: Original Article
MINI SYMPOSIUM: MOLECULAR ONCOLOGY: Original Article
MINI SYMPOSIUM: PEDIATRIC ONCOLOGY: Original Article
MISCELLANEOUS : Original Article
MOLECULAR ONCOLOGY : Original Article
MULTIPLE CANCERS Original Article
MYELODYSPLASTIC SYNDROME : Review Article
MYELOID LEUKEMIA : Original Article
NEURO ONCOLOGY : Review Article
NEURO-ONCOLOGY : Original Article
None
Notice of Retraction
OESOPHAGEAL CANCER : Original Article
Oncology Reflections
Original Article
Original Article : Bone & Soft Tissue Tumors
ORIGINAL ARTICLE : Bone and Soft Tissue Sarcomas
ORIGINAL ARTICLE : Breast Cancer
Original Article : Breast Cancers
Original Article : Gastro-intestinal & Hepatobiliary Cancers
Original Article : Genitourinary & Gynecological Cancers
ORIGINAL ARTICLE : GI Cancer
ORIGINAL ARTICLE : GI Oncology
ORIGINAL ARTICLE : Gynaecologic Oncology
Original Article : Head and Neck Cancers
ORIGINAL ARTICLE : Hematolymphoid
Original Article : Leukemia & Lymphoma
ORIGINAL ARTICLE : Leukemia and Lymphoma
ORIGINAL ARTICLE : Melanoma and Skin Cancer
Original Article : Pediatric and Adolescent Cancers
ORIGINAL ARTICLE : SAARC Selection
ORIGINAL ARTICLE : Supportive Care and Others
Original Article, Breast
Original Article, Gastrointestinal
Original Article, Gynaecological
Original Article, Head Neck
Original Article, Neurological
Original Article, Public Health
Original Article: Bladder Cancer
Original Article: Bone and Soft Tissue Cancers
Original Article: Bone and Soft Tissue Tumor
ORIGINAL ARTICLE: Bone and Soft Tissue Tumors
Original Article: Brain Tumor
ORIGINAL ARTICLE: Brain Tumors
Original Article: Cancer Epidemiology and Screening
Original Article: Cancer Epidemiology, Screening and diagnosis
ORIGINAL ARTICLE: Diagnostics in Oncology
ORIGINAL ARTICLE: Epidemiology of Cancer and Cancer Screening
ORIGINAL ARTICLE: Gastro-intestinal & Hepatobiliary Cancer
Original Article: Gastrointestinal Cancer
Original Article: Genito Urinary Cancer
ORIGINAL ARTICLE: Genitourinary & Gynaecological Cancer
Original Article: Genitourinary Cancer
ORIGINAL ARTICLE: Genitourinary Cancers
Original Article: Geriatric Oncology
ORIGINAL ARTICLE: GI Cancers
Original Article: GI Cancers and Hepatobilliary Malignancies
ORIGINAL ARTICLE: Gynaecologic Cancers
ORIGINAL ARTICLE: Gynaecological Cancer
ORIGINAL ARTICLE: Gynaecological Cancers
Original Article: Gynecological Cancer
ORIGINAL ARTICLE: Head and Neck Cancer
ORIGINAL ARTICLE: Hematolymphoid Malignancies
Original Article: Hematolymphoid Malignancy
Original Article: Hepatobiliary Cancer
ORIGINAL ARTICLE: Immuno - Oncology
Original Article: Leukemia -Lymphoma and Myeloma
ORIGINAL ARTICLE: Leukemia, Lymphoma & Plasma Cell Disorder
Original Article: Lung Cancer
ORIGINAL ARTICLE: Lung Cancers
ORIGINAL ARTICLE: Neuroendocrine Tumors
Original Article: Paediatric Cancer
ORIGINAL ARTICLE: Palliative Care
ORIGINAL ARTICLE: Pediatric Oncology
ORIGINAL ARTICLE: Sarcomas
ORIGINAL ARTICLE: Sarcomas and Skin Cancer
Original Article: Skin Cancer
Original Article: Supportive and Palliative Care
Original Article: Supportive and Palliative Care in Cancer
ORIGINAL ARTICLE: Supportive Care
Original Research Article
PEDIATRIC ONCOLOGY : Original Article
PEDIATRIC SECTION: Editorial
PEDIATRIC SECTION: Original Article
Pictorial CME, Haematological
Poetry in Oncology
Position Paper
QUEST FOR AN ANTIDOTE TO RADIATION TOXICITY : Editorial
QUEST FOR AN ANTIDOTE TO RADIATION TOXICITY : Original Article
RCC Practical Consensus Recommendations
Regional Article
Review Article
Review Article, Breast
Review Article, Haematological
Review Article, International
SARCOMA : Original Article
SARCOMA Review Article
SOFT TISSUE SARCOMA : Original Article
South Asia update
SOUTH ASIAN UPDATE : An update
SOUTH ASIAN UPDATE : Original Article
TABACCO, THE MENACE : Original Article
THE CUTTING EDGE OF RADIOTHERAPEUTICS : Editorial
THE CUTTING EDGE OF RADIOTHERAPEUTICS : Original Article
THE GREAT DEBATE: Against HPV vaccine in cervical cancer
THE GREAT DEBATE: AGAINST IMATINIB AS THE FIRST LINE TKI CHOICE FOR CML
THE GREAT DEBATE: Editorial-HPV vaccine in cervical cancer
THE GREAT DEBATE: For HPV vaccine in cervical cancer
THE GREAT DEBATE: FOR IMATINIB AS THE FIRST LINE TKI CHOICE FOR CML
THE GREY-HAIRED CANCER PATIENT: Editorial
THE GREY-HAIRED CANCER PATIENT: Original Article
THE SKILLFUL SCALPEL: Editorial
THE SKILLFUL SCALPEL: Original Article
THE WAR ON MICROBES: Editorial
THE WAR ON MICROBES: Original Article
THROUGH THE MICROSCOPE : Original Article
THROUGH THE MICROSCOPE: Editorial
TREATMENT TOXICITY : Original Article
TRENDS IN HORMONAL THERAPY IN PROSTATE CANCER: Review Article
URO-ONCOLOGY : Original Article
View Point
Viewpoint
View/Download PDF

Translate this page into:

Original Article
14 (
04
); 827-831
doi:
10.1055/s-0043-1771408

Improving Patient Wait Times on the First Day of Radiotherapy Treatment

Department of Radiation Oncology, Tata Memorial Centre, Mumbai, Maharashtra, India
Homi Bhabha National Institute, Mumbai, Maharashtra, India
Department of Medical Physics, Tata Memorial Centre, Mumbai, Maharashtra, India
Department of Palliative Medicine, Tata Memorial Centre, Mumbai, Maharashtra, India
Executive Director of Operations, Stanford Health Care, California, United States
Author image
Corresponding author: Rahul Krishnatry, MD, Mumbai 400012, Maharashtra, India. krishnatry@gmail.com
Licence
This is an open-access article distributed under the terms of the Creative Commons Attribution-Non Commercial-Share Alike 4.0 License, which allows others to remix, transform, and build upon the work non-commercially, as long as the author is credited and the new creations are licensed under the identical terms.
Disclaimer:
This article was originally published by Thieme Medical and Scientific Publishers Pvt. Ltd. and was migrated to Scientific Scholar after the change of Publisher.

Abstract

Abstract

Long wait times on starting day of radiotherapy (day 1) can cause dissatisfaction among both patients and healthcare providers. Reducing these wait times will decrease stress and decongest hospital facilities especially in current coronavirus disease 2019 times. A multidisciplinary core team was formed during the Stanford-India Collaborative Quality Improvement training to reduce the median wait times on day 1 of treatment from 6 to 4.5 hours (a 25% reduction). Several factors were identified on the fishbone diagram, and key causes were identified using a Pareto chart and action prioritization matrix. The Plan-Do-Study-Act Cycle strategy was undertaken for the identified interventions. The outcome measure was time from arrival at the hospital to entry into a treatment room. Data were obtained from time charts at various stations and electronic records. The secondary measures were visual analog scale (VAS) scores, 80th percentile wait times, and the day-2 delay percentage. The balancing measure was “new errors” due to interventions. The interventions included the completion of all administrative tasks not needing patients' presence on the day before day 1. Baseline data from 198 patients and postintervention data from 160 patients were compared and analyzed. The median wait time at baseline, which was 6 hours, was reduced to 4.2 hours. The VAS score showed 70.4, 67.7, and 71.9% satisfaction for the resident physician, therapists, and patients, respectively. The 80th percentile wait times reduced from 8 to 5.7 hours; and the day 2 starting rate decreased from 22.5 to 2.04%, with no new errors reported. Radiotherapy day 1 wait times can be safely decreased, leading to improved satisfaction among patients and healthcare providers, by utilizing classic quality improvement methods and tools.

Keywords

PubMed

Introduction

Our institute (Tata Memorial Centre, Mumbai) is a large comprehensive cancer center in South-East-Asia. About 7,000 patients receive external beam radiotherapy (RT) yearly with six linear accelerators and four telecobalt distributed at three locations.1 The public and privately funded patients share the same machine space in 60:40 ratio. The RT process begins in the outpatient clinic with evaluation, treatment appointments, and simulation. To achieve a desired treatment plan, a long, complex pathway is followed by the medical team comprising physicians, physicists, and therapists. This process involves patient information transiting repeatedly through several human–machine and human–human interfaces.2 Once the machine slot availability is confirmed, the patient is informed to report for treatment initiation. On the first day of the radiation treatment (day 1), several administrative tasks are undertaken such as confirmation of machine slot, payment, electronic record, and other documents (consent forms) preparation, and mobilizing accessories (e.g., immobilization devices) to machines. Day 1 is crucial, as all the planning and clinical information are compiled and verified to ensure safe and accurate treatment. The patient/attendant moves through various stations to help complete these tasks with their care team. On following treatment days, patients directly report to respective treatment units and treatment is provided with minimal delays.

Previously literature has focused on reducing wait times for RT appointments or planning process times.234 We noticed no literature addressing wait times on day 1 of RT. The several steps on day 1 may result in long wait times for patients and attendants, and at times the delays in the completion of certain tasks such as e-RT charts or plan implementation may defer treatment to the second day (day 2). These wait times can be frustrating for patients and healthcare providers leading to dissatisfaction, distress, and overcrowding of finite waiting space. The additional stress on the healthcare team may lead to treatment errors and adversely affect the quality of patient care.5 Our study aimed at reducing the wait times on day 1 of RT and improving the patient experience.

Patients and Methods

A core multidisciplinary team (two physicians, one medical physicist, and two therapists) participated in the “Enable Quality Improve Patient Care (EQuIP),” a Stanford-India Collaborative Quality Improvement (QI) training project 2019 to 2020. Other team members included the Quality Training Program mentors (two institutional and one international). This study was undertaken as a QI initiative at Tata Memorial Centre, Mumbai rather than a human participant research and therefore exempted from institutional review board approval.

For baseline data collection, all patients visiting the hospital on day-1 for RT initiation were included (with an exception of those requiring urgent palliative treatment) for 2 months. Wait times from entry into the hospital to the treatment machine for delivery were recorded manually and electronically from various stations such as reporting counter with a physician, e-RT chart completion, payment completion, plan implementation completion, reporting at the machine, and treatment execution. These were verified with the patients individually after the treatment delivery by various treatment unit therapists. All consecutive patients' day 1 time over a 2-week period was collated to derive the median day 1 time (hours).

During the baseline period, the median day 1 wait times was 6 (range: 5.7–6.5) hours. The median 80th percentile time was 8.2 (7.4–8.3) hours with 20 (5.4–22.5) % of patients waiting till day 2. The “SMART goal” (Specific, Measurable, Achievable, Relevant, and Time-Bound) was identified as “to reduce the median Day one wait times from 6 to 4.5 hours (1.5 hours reduction; 25%) over a period of 6 months.”

The team met weekly during the project and attended online lectures on various steps of QI monthly, with one hands-on visit in the middle of the project. To begin with, we reviewed the day 1 process through repeated site observations to ascertain the process map and identify various probable causes for delays. The semantic preintervention patient pathways are shown in Fig. 1. To understand actionable delays, the day 1 time was broken into various component activities documenting care provider and patient involvement. Baseline data from 198 patients were collected in total. A fishbone diagram was developed to determine the cause and effect of the current delays (Fig. 2). Several meetings with varied disciplines involved in the patient pathway on day 1 were held to review the process map and fishbone diagram. As a team, the providers were asked to prioritize the most frequent causes for delays using a Pareto chart and interventions were designed around those areas that were easiest to implement and provided the highest benefit for patients and the care provider team (Action-Priority-Matrix).

Process map.
Fig. 1: Process map.
Fishbone diagram.
Fig. 2: Fishbone diagram.

Plan-Do-Study-Act Cycle 1 (PDSAC): Patients on day 1 usually waited to complete several administrative formalities before receiving treatment. Once the process steps were documented, it was observed that the patient's presence was not required for these tasks. As a first intervention, it was deemed necessary that these tasks should be completed before the patient reported to the hospital. To accomplish this goal, a set of interventions were required including (1) confirmation of machine vacancy, (2) completion of e-RT charts using patient plan printout that would be check-in/checked out, and (3) development of a patient checklist for day 1 where instructions regarding reporting (time/place) and payment were carefully outlined. After several briefing sessions with the team, all interventions were launched simultaneously starting on January 10, 2020.

PDSAC 2: For the first 2 weeks postintervention, new data points were added, such as visual analog scale (VAS) score for satisfaction (resident physicians, therapists, and patients) and e-RT chart transcriptional errors. It was noted that there were inconveniences in completing e-RT charts timely due to the single-time movement of documents per day. Hence, arrangements were made to allow these three times a day. The PDSAC-1 took place from January 10 to 24 2020, followed by 2nd cycle till February 28, 2020, including 160 patients.

The primary measure was the median time for treatment initiation on day 1 (hours). The secondary outcomes included the number of patients per time block, 80th percentile wait time(hours), percentage of patients starting day 2, and VAS scores (scores of “0” and “100” meant extremely dissatisfied and satisfied respectively) from treating resident physician, therapist, and patient. The balancing measure was the identification of any transcriptional errors.

Data Analysis

We used a run chart to objectively examine the median wait time change from baseline to PDSACs. The patient's wait times were arranged in ascending order to detect the wait times for the 80th percentile patient in each time block. The VAS scores were calculated as mean % for the whole PDSAC period.

Results

During the PDSAC-1, all described interventions were launched after a mock drill to understand ground challenges and were mitigated beforehand, as it was a major workflow change. For example, the day before machine vacancy prediction was practiced for concurrence for 2 weeks beforehand to get the expected error rate and its adjustability. Similarly, the residents were trained with a proper checklist so that they know the complete information to be provided to the patients. Once the team was confident of implementing all the steps, then only it was implemented. For the first few days, compliance to patient instructions and prior administrative paperwork was 60%, but over 3 days it reached a satisfactory level of 95% and was maintained thereafter. The median day 1 wait times and 80th percentile time dropped to 5.3 and 7 hours, respectively, with day 2 treatment at 5.4% during PDSAC-1.

In PDSAC-2, the median day 1 wait times and 80th percentile time further decreased to 4.2 (70% decline; Fig. 3) and 5.7 hours, respectively, with day 2 treatment in 1.5%. There was 100% compliance for prior machine confirmation and e-RT chart completion improved from 50 to 95% from cycles 1 to 2. The VAS score showed 78.5, 75.5, and 79.3% satisfaction for the resident physician, therapists, and patients, respectively. There were no new errors detected during PDSAC-1&2.

Run chart.
Fig. 3: Run chart.

The aim of this initial study was achieved. However, additional QI interventions are planned with the provider team to reduce the variation observed in plan implementation and on-machine waiting time. Due to the implementation of coronavirus disease 2019 (COVID-19) precautions in March 2020, further interventions were halted and will be considered in future.

Discussion

Our study demonstrated a 1.8-hour reduction in the median wait times on the first day of RT treatment (day 1) that exceeded the target aim before starting the study. We noticed a consistent improvement in all secondary measures as well.

The reduced time spent in the hospital may also reduce the chances of nosocomial infection and spreading infections such as COVID-19. The reduction in the number of hours patients/attendants spend RT waiting for areas further emboldens the basic principle of RT, “ALARA” (as low as reasonably achievable).6 Patients may be able to use this time to ease their travel schedule to the hospital and may spend it on their activity of choice. It is estimated that with the current reduction, the patient would save 10,800 person-hours per year and the hospital would save 21,600 seating space hours in waiting areas every year. The multidisciplinary team is also less stressed and it was remarkable that no transcriptional errors were reported during the PDSACs compared to prior reports from our institutional audit.5 We plan to sustain these interventions to see the long-term effects on patients and the care team.

Previously, we have tried several times to reduce wait times on day 1 but were largely unsuccessful. The key to successfully reducing patient wait times was the development of a culture for improvement at the local level. This experience allowed the multidisciplinary team to have an open dialogue and use standard QI tools to outline each process step before interventions were tested or implemented. The administrative support from the department and hospital was also crucial to support proposed process changes and remove barriers to implementation. We believe our experience will be a useful guide to other large busy academic centers to help improve their patient care quality and wait times. Also, a similar system can be extrapolated to other hospital areas. However, a single-center study and exact baseline wait times and challenges may not be applicable to other centers directly. But if we look closely, basic problems such as precompletion of administrative paperwork for patients and good comprehensive patient communication addressed the underlying problems/bottlenecks/wastes. These may guide them in similar problems in their conditions as well. Of these continued clear communication with all the information can be difficult to sustain in centers where it is by temporary or rotating staff. It would be important to establish a checklist of instructions so that it is sustained (Table 1).

Table 1
Strategies to improve wait times on day 1 of radiotherapy treatment

S. No.

1

Completion of paper work and other administrative formalities prior to patient arrival to the hospital

2

Clear communication with the patient regarding place, time of reporting, billing formalities and any specific protocol such as fasting and premedication

3

Keeping time stamps to understand the times

4

Collect patient feedback and satisfaction scores

This study is important from the Indian perspective, as we have unique challenges related to the large number of patients that we treat every day with skewed recourses every day at almost all centers.7 The wider implementation of audits in the systems is catching up to understand the scopes of quality improvement programs implementation.58 We have similarly shown, previously, complex problems can be mitigated for the long term through a systematic quality improvement approach.9 We hope, with the help of the research wing in EQUiP India under the National Cancer Grid, various government and private centers with radiation oncology departments in the country would review their wait times and look for larger concurrence and variabilities in causes and interventions related to it.

Acknowledgment

This work was conducted under the aegis of a collaborative Quality Improvement training project “EQuIP 2019-20” (Enable Quality Improve Patient Care), envisioned by Stanford- India (Stanford Medicine, California; Tata Trust and National Cancer Grid India). We acknowledge the guidance and support of Mr. Jake Mickelsen (Stanford) during the QI training and manuscript editing. We also acknowledge support and guidance from Dr. Nandini Vallath and Ms. Vanessa Damania (Tata Trust) and Dr C.S. Pramesh (NCG, India; Director TMH, Mumbai) during the QI training.

References

  1. Accessed July 10, 2023 at:
  2. , , , et al . The timeliness initiative: continuous process improvement for prompt initiation of radiation therapy treatment. Adv Radiat Oncol. 2020;5(05):1014-1021.
    [Google Scholar]
  3. , , , et al . Quantitative survival impact of composite treatment delays in head and neck cancer. Cancer. 2018;124(15):3154-3162.
    [Google Scholar]
  4. , , , et al . Time to treatment as a quality metric in lung cancer: staging studies, time to treatment, and patient survival. Radiother Oncol. 2015;115(02):257-263.
    [Google Scholar]
  5. , , , et al . An audit for radiotherapy planning and treatment errors from a low-middle-income country centre. Clin Oncol (R Coll Radiol). 2019;31(01):e67-e74.
    [Google Scholar]
  6. , . The “As Low As Reasonably Achievable” (ALARA) principle: a brief historical overview and a bibliometric analysis of the most cited publications. Radioprotection. 2019;54(02):103-109.
    [Google Scholar]
  7. , , , et al . Modern radiotherapy technology: obstacles and opportunities to access in low- and middle-income countries. JCO Glob Oncol. 2022;8:e2100376.
    [Google Scholar]
  8. , , , , . Quality and safety with technological advancements in radiotherapy: an overview and journey narrative from a low- and middle-income country institution. JCO Glob Oncol. 2022;8:e2100367.
    [Google Scholar]
  9. , , , et al . Quality improvement process with incident learning program helped reducing transcriptional errors on telecobalt due to mismatched parameters in different generations. J Med Phys. 2022;47(04):367-373.
    [Google Scholar]
Show Sections